A. Carta, P. Sanna, L. Gherardini, D. Usai and S. Zanetti, “Novel Functionalized Pyrido[2,3-9]Quinoxalinones as Antibacterial, Antifungal and Anticancer Agents,” Il Farmaco, Vol. 56, No. 12, 2001, pp. 933-938. doi:10.1016/S0014-827X(01)01161-2

has been cited by the following article:

• TITLE: Synthesis and Influence of Two Quinoxalinone Derivatives on Anxiety- and Depressive-Like Responses in Wistar Rat

  AUTHORS: Redouan Nakache, Brahim Lakhrissi, Fatima Zahra El Mrabet, Aboubaker Elhessni, Ali Ouichou, Bouchra Benazzouz, Abdelhalem Mesfioui

  KEYWORDS: Depression; Anxiety; Quinoxalinone Derivatives; Locomotor Activity; Wistar Rats

  JOURNAL NAME: Neuroscience and Medicine, Vol.3 No.4, December 26, 2012

  ABSTRACT: Two new quinoxalinone derivatives have been synthesized adopting the HONG method, and investigated for some neuropharmacological effects (anxiety- and depressive-like responses) in rats. The present experiment sought to determine whether treatment with these compounds produces changes in affective responses. We found that the chronic injection of 6-nitro-2(1H)-quinoxalinone (NQu) showed obvious anxiolytic- and antidepressant-like effects, respectively, measured in the behavioral tests of Elevated Plus Maze (EPM) and Forced Swim Test (FST). At the dose of 30 mg/kg, NQu showed a comparative anxiolytic-like effect in rats as diazepam (Dz) (1 mg/kg), and a comparative antidepressant effect as clomipramine (Clmp) (2 mg/kg; i.p). The 2(1H)-quinoxalinone (Qu) significantly reduced depressive-like responses as evaluated in FST, whereas no anxiolytic-like effect was found as measured by open field test (OF). Additionally, the locomotor activity levels were unaffected by treatment as measured by OF and EPM.